Next-generation psychedelics biotech Cybin Inc. (NYSE: CYBN) released the full Phase 2 trial results of its deuterated psilocybin derivative CYB003 for Major Depressive Disorder (MDD.) Although a relatively small trial, outcomes for the novel psychedelic are so far showing st
The legal standoff that has prevented cannabis dispensaries across New York State from getting their licenses to operate was resolved late Friday when the NY Supreme Court lifted an injunction preventing the Office of Cannabis Management (OCM) from processing Conditional Adult Use Retail Dispensary —or CAURD— dispensary licenses.
German lawmakers are expecting a recently revised version of the marijuana legalization measure to bring about the long-awaited policy change in the coming spring.
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Friday that it has closed the sale of BioSteel Canada and BioSteel Manufacturing, LLC for gross proceeds of $30.4 million.